Form 8-K - Current report:
SEC Accession No. 0001104659-19-020072
Filing Date
2019-04-05
Accepted
2019-04-05 10:03:54
Documents
9
Period of Report
2019-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7895_18k.htm 8-K 37817
2 EX-5.1 a19-7895_1ex5d1.htm EX-5.1 17975
3 EX-10.1 a19-7895_1ex10d1.htm EX-10.1 360135
4 EX-10.2 a19-7895_1ex10d2.htm EX-10.2 168649
5 EX-10.3 a19-7895_1ex10d3.htm EX-10.3 167575
6 EX-99.1 a19-7895_1ex99d1.htm EX-99.1 15427
7 EX-99.2 a19-7895_1ex99d2.htm EX-99.2 19670
8 GRAPHIC g78951mmi001.gif GRAPHIC 2999
9 GRAPHIC g78951moi001.gif GRAPHIC 2999
  Complete submission text file 0001104659-19-020072.txt   797239
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Trovagene, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 19733695
SIC: 2836 Biological Products, (No Diagnostic Substances)